Company: TBPH
Filing Date: 2025-11-10
Form Type: 8-K
Source: 0001104659-25-109146
Chunk: 1

Company: Theravance Biopharma, Inc.
Filing Date: 2025-11-10
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item
9.01. Financial Statements and Exhibits.

(d)
Exhibits.

  99.1      Press                                                                                             
            Release dated November 10, 2025                                                                   
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────
  99.2      Slide deck entitled Third Quarter 2025 Financial Results and Business Update                      
   104      Cover Page Interactive Data File (cover page XBRL tags embedded within the Inline XBRL document)  

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                               THERAVANCE BIOPHARMA, INC.                                       
  Date: November 10, 2025      By:                             /s/                              
                                                               Aziz Sawaf                       
                                                               Senior Vice President and Chief